Related Experiment Video
Updated: May 13, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Practice implications of the Atrial Fibrillation Guidelines
1University at Buffalo, The State University of New York, Buffalo, NY, USA. abcurtis@buffalo.edu
The American Journal of Cardiology
|March 20, 2013
Summary
Updated atrial fibrillation guidelines from major cardiology societies offer new insights into rhythm control, complication management, and thromboprophylaxis. This review compares key recommendations for optimal patient care.
Area of Science:
- Cardiology
- Clinical Medicine
- Evidence-Based Practice
Background:
- Atrial fibrillation (AF) is a prevalent and complex cardiac arrhythmia.
- Current evidence informs management recommendations by leading medical societies.
- Recent guideline updates from European, Canadian, and US societies necessitate a comparative review.
Purpose of the Study:
- To compare and contrast recent updates from four major atrial fibrillation guideline consensus groups.
- To highlight key revisions in AF management strategies.
- To provide a consolidated overview for clinicians.
Main Methods:
- Comparative analysis of updated guidelines from the European Society of Cardiology, American College of Chest Physicians, Canadian Cardiovascular Society, and a US task force.
- Focused review on specific areas of guideline revision.
- Synthesis of similarities and differences in recommendations.
Main Results:
- Guidelines incorporate newer treatments for rhythm control in atrial fibrillation.
- Updated recommendations address options for reducing AF-related complications.
- Significant revisions are noted in anticoagulant management for thromboprophylaxis.
Conclusions:
- Recent guideline updates provide a refined approach to atrial fibrillation management.
- Clinicians should be aware of the nuances between different international and national recommendations.
- The updated guidelines emphasize advancements in AF treatment and prevention strategies.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...